Galactooligosaccharide, Immune Strength, and Digestive Health
NCT ID: NCT01137760
Last Updated: 2012-08-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
427 participants
INTERVENTIONAL
2009-10-31
2010-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sugar pill
Sucrose
5 g of sucrose daily for 8 weeks
Galactooligosaccharide 2.5 g
Galactooligosaccharide
2.5 g galactooligosaccharide plus 2.5 g sucrose daily for 8 weeks
Galactooligosaccharide 5.0 g
Galactooligosaccharide
5.0 g galactooligosaccharide daily for 8 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sucrose
5 g of sucrose daily for 8 weeks
Galactooligosaccharide
2.5 g galactooligosaccharide plus 2.5 g sucrose daily for 8 weeks
Galactooligosaccharide
5.0 g galactooligosaccharide daily for 8 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* willing to complete a daily assessment form via computer
* willing to discontinue any immune-enhancing dietary supplements ( e.g., prebiotics and fiber supplements, probiotics, echinacea, fish oil, vitamin E \>100% of the RDA or \>15 mg/day)
* willing to take the fiber for 8 weeks
* had a cold in last 12 months
* have at least 1 final during the Fall 2009 exam week, between Saturday, December 12 and Friday, December18, 2009
* daily access to a computer with Internet access for the entire 8-wk study
Exclusion Criteria
* chronic allergies involving the upper respiratory tract (Chronic = taking allergy medicine daily)
* an allergy to milk
* known illnesses or conditions that may impact perceived health such as HIV/AIDS, diabetes, renal or gastrointestinal diseases
* received chemotherapy or other immune suppressing therapy within the last year
* antibiotic therapy in the past two months
* a cold or cold symptoms (on day of randomization)
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GTC Nutrition
INDUSTRY
University of Florida
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bobbi Langkamp-Henken, PhD, RD
Role: PRINCIPAL_INVESTIGATOR
University of Florida
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Florida
Gainesville, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hughes C, Davoodi-Semiromi Y, Colee JC, Culpepper T, Dahl WJ, Mai V, Christman MC, Langkamp-Henken B. Galactooligosaccharide supplementation reduces stress-induced gastrointestinal dysfunction and days of cold or flu: a randomized, double-blind, controlled trial in healthy university students. Am J Clin Nutr. 2011 Jun;93(6):1305-11. doi: 10.3945/ajcn.111.014126. Epub 2011 Apr 27.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
307-2009
Identifier Type: -
Identifier Source: org_study_id